These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 2033366)
1. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. Gadina M; Bertini R; Mengozzi M; Zandalasini M; Mantovani A; Ghezzi P J Exp Med; 1991 Jun; 173(6):1305-10. PubMed ID: 2033366 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect on LPS-induced tumor necrosis factor in calves treated with chlorpromazine or pentoxifylline. Ohtsuka H; Higuchi T; Matsuzawa H; Sato H; Takahashi K; Takahashi J; Yoshino TO J Vet Med Sci; 1997 Nov; 59(11):1075-7. PubMed ID: 9409530 [TBL] [Abstract][Full Text] [Related]
3. Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. Mengozzi M; Fantuzzi G; Faggioni R; Marchant A; Goldman M; Orencole S; Clark BD; Sironi M; Benigni F; Ghezzi P Immunology; 1994 Jun; 82(2):207-10. PubMed ID: 7927490 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of chlorpromazine against the lethality of interleukin 1 in adrenalectomized or actinomycin D-sensitized mice. Bertini R; Bianchi M; Mengozzi M; Ghezzi P Biochem Biophys Res Commun; 1989 Dec; 165(3):942-6. PubMed ID: 2692568 [TBL] [Abstract][Full Text] [Related]
5. Regulation of serum tumor necrosis factor in glucocorticoid-sensitive and -resistant rodent endotoxin shock models. Zuckerman SH; Bendele AM Infect Immun; 1989 Oct; 57(10):3009-13. PubMed ID: 2777371 [TBL] [Abstract][Full Text] [Related]
6. Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. Gatti S; Faggioni R; Echtenacher B; Ghezzi P Clin Exp Immunol; 1993 Mar; 91(3):456-61. PubMed ID: 8443968 [TBL] [Abstract][Full Text] [Related]
7. Chlorpromazine protection against interleukin-1 and tumor necrosis factor-mediated activities in vivo. Bertini R; Mengozzi M; Bianchi M; Sipe JD; Ghezzi P Int J Immunopharmacol; 1991; 13(8):1085-90. PubMed ID: 1814847 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats. Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803 [TBL] [Abstract][Full Text] [Related]
9. Differential protective activities of site specific lipoxygenase inhibitors in endotoxic shock and production of tumor necrosis factor. Schade UF; Engel R; Jakobs D Int J Immunopharmacol; 1991; 13(5):565-71. PubMed ID: 1783470 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686 [TBL] [Abstract][Full Text] [Related]
11. Contradictory effects of chlorpromazine on endothelial cells in a rat model of endotoxic shock in association with its actions on serum TNF-alpha levels and antioxidant enzyme activities. Can C; Demirci B; Uysal A; Akçay YD; Koşay S Pharmacol Res; 2003 Sep; 48(3):223-30. PubMed ID: 12860438 [TBL] [Abstract][Full Text] [Related]
12. Contribution of tumor necrosis factor-alpha and glucocorticoid in hydrazine sulfate-mediated protection against endotoxin lethality. Johnson DC; Freudenberg MA; Jia F; Gonzalez JC; Galanos C; Morrison DC; Silverstein R Circ Shock; 1994 May; 43(1):1-8. PubMed ID: 7982269 [TBL] [Abstract][Full Text] [Related]
13. Chlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitro. Zinetti M; Galli G; Demitri MT; Fantuzzi G; Minto M; Ghezzi P; Alzani R; Cozzi E; Fratelli M Immunology; 1995 Nov; 86(3):416-21. PubMed ID: 8550079 [TBL] [Abstract][Full Text] [Related]
14. Animal models of endotoxic shock. Villa P; Ghezzi P Methods Mol Med; 2004; 98():199-206. PubMed ID: 15064441 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. Sha T; Sunamoto M; Kitazaki T; Sato J; Ii M; Iizawa Y Eur J Pharmacol; 2007 Oct; 571(2-3):231-9. PubMed ID: 17632100 [TBL] [Abstract][Full Text] [Related]
16. In vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction. Zuckerman SH; Qureshi N Infect Immun; 1992 Jul; 60(7):2581-7. PubMed ID: 1612727 [TBL] [Abstract][Full Text] [Related]
17. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. Bertini R; Bianchi M; Ghezzi P J Exp Med; 1988 May; 167(5):1708-12. PubMed ID: 3259257 [TBL] [Abstract][Full Text] [Related]
18. Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice. Chorinchath BB; Kong LY; Mao L; McCallum RE J Immunol; 1996 Feb; 156(4):1525-30. PubMed ID: 8568256 [TBL] [Abstract][Full Text] [Related]
19. Effects of chlorpromazine on PMN-mediated activities in vivo and in vitro. Bertini R; Wang JM; Mengozzi M; Willems J; Joniau M; Van Damme J; Ghezzi P Immunology; 1991 Jan; 72(1):138-43. PubMed ID: 1997397 [TBL] [Abstract][Full Text] [Related]
20. Influence of endogenous glucocorticoid on endotoxin-induced production of circulating TNF-alpha. Parant M; Le Contel C; Parant F; Chedid L Lymphokine Cytokine Res; 1991 Aug; 10(4):265-71. PubMed ID: 1932370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]